Health Minister Ma Subramanian launched a drive to administer Corbevax booster doses to recipients aged 18 years and above in Tamil Nadu on Friday.
This is the first time a booster dose different from the one used for primary vaccination against Covid has been allowed in India.
The approval will be based on the recommendations made by the COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) last week.
India's first indigenously developed RBD protein subunit vaccine Corbevax is currently being used to inoculate children in the age group of 12 to 14 years.
However, there was no decision on introducing these vaccines in the vaccination programme.
The Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precaution dose for those aged 18 and above.
NTAGI to discuss allowing Corbevax as booster for those vaccinated with Covishield, Covaxin: Sources
The Drugs Controller General of India (DCGI) on Sunday approved Corbevax for the precaution dose for those aged 18 and above.
Heterologous booster immunisation provides an immune response that may prove to be beneficial for durable prevention and control of Covid-19.
With this, Biological E Limited's Corbevax has become the first Covid-19 vaccine in India to be approved by the DCGI as a heterologous Covid-19 booster dose.
For end-user, the price would be Rs 400 a dose, including taxes and administration charges, added the pharmaceutical company.
The new approvals were tweeted by Union Health Minister Dr Mansukh Mandaviya, who said that India's fight against Covid has become more robust.
The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12 to 17 years age group.
While plans had been drawn to conduct the drive across several schools, the same has been postponed to Monday.
The MP immunisation director also said that 11.43 core doses of anti-COVID-19 vaccines have been administered so far in the state.
Tirupathur Collector Amar Khushhwaha inaugurated the vaccination drive at Meenakshi Government Women's Higher Secondary School in the district.
In the process of vaccine approvals, after the DCGI’s nod, the NTAGI deliberates on this and screens the ability of the vaccine to be part of the national vaccination drive at a three-level process.
While the vaccination centres were open at 8 am, teenagers were seen making beelines at several places since morning.
The company has produced 30 crore doses of the same and has supplied five crore doses to the government of India.
Union Health Secretary Rajesh Bhushan had earlier stated that only the Corbevax vaccine would be used for the beneficiaries in the age group of 12 to 14 years.
Vaccination will be done only in govt units, free of cost